QUESTRAN LITE 4G powder sachet Australia - English - Department of Health (Therapeutic Goods Administration)

questran lite 4g powder sachet

viatris pty ltd - colestyramine, quantity: 850 mg/g - powder, oral - excipient ingredients: xanthan gum; colloidal anhydrous silica; citric acid; aspartame; propylene glycol alginate; flavour - indications as at 1 january 1991 : 1. reduction of serum cholesterol levels and prevention of coronary heart disease. questran lite is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoproteins). questran lite may be useful to lower elevated cholesterol that occurs in patients with combined hypercholesterolemia and hypertriglyceridemia, but it is not indicated where hypertriglyceridemia is the abnormality of most concern. 2. relief of pruritus associated with partial biliary obstruction. patients with primary biliary cirrhosis may exhibit elevated serum cholesterol as part of their disease. when cholestyramine is used to treat the pruritus of partial biliary obstruction, it may lower serum cholesterol levels, produce no change, or cause rapid escape from a temporary lowering to pre-treatment levels or rebound. 3. relief of diarrhoea following ileal resection or ileal disease (cholerrhoeic enteropa

Colestyramine 4g oral powder sachets sugar free United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

colestyramine 4g oral powder sachets sugar free

alliance healthcare (distribution) ltd - colestyramine anhydrous - powder for oral suspension - 4gram